Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Agilon Health Q1 2024 GAAP EPS $0.01 Beats $(0.01) Estimate, Sales $1.604B Inline

Author: Benzinga Newsdesk | May 07, 2024 04:32pm
Agilon Health (NYSE:AGL) reported quarterly earnings of $0.01 per share which beat the analyst consensus estimate of $(0.01) by 200 percent. The company reported quarterly sales of $1.604 billion which met the analyst consensus estimate. This is a 41.20 percent increase over sales of $1.136 billion the same period last year.

Posted In: AGL

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist